
Otezla: An oral pill for plaque psoriasis, psoriatic arthritis and the mouth ulcers of Behcet's disease. It needs no routine blood tests, and it is gentler and less powerful than the injected treatments. Sotyktu: A once-daily tablet for moderate to severe plaque psoriasis. It blocks TYK2, an enzyme inside immune cells, and is taken by mouth rather than injected.


Choose for moderate psoriasis or psoriatic arthritis when you want a pill with no routine blood tests, accepting it's gentler than injections.
Choose for moderate to severe psoriasis when you want a once-daily pill rather than injections.
Can you take them together?
Both are daily psoriasis tablets. Choose one; Sotyktu is often more effective, Otezla has a longer track record.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.










Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Psoriasis plaques become less inflamed.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.

Inhibits TYK2: Keeps this signaling enzyme in an inactive state. Reduces immune messages: Limits signals from IL-23, IL-12, and type I interferons. Helps psoriasis settle: Inflammation and plaque buildup gradually decrease.
Deucravacitinib allosterically binds the regulatory domain of TYK2. The exact link between biomarker changes and clinical effects is not fully known.
Nothing about the dose depends on weight or on how severe your disease is. It is built up gradually only to give your stomach time to settle.
Starting dose: A five-day starter pack, beginning at 10 mg on day one and climbing in 10 mg steps, morning and evening doses in turn, until you reach 30 mg twice a day on day six.
Usual dose: 30 mg twice a day, about 12 hours apart.
If your kidneys are significantly impaired: The dose is halved to 30 mg once a day, and the starter pack is used differently.
Total course: No fixed course. It is taken as long as it helps, judged at about 16 weeks, and the benefit stops when the drug stops.
Dosing is as simple as it gets for a systemic drug. No loading dose, no build-up, no weight adjustment.
Starting dose: 6 mg once a day from day one. Full dose from the start.
Going up: No higher approved dose for psoriasis. If it is not working, the conversation is about switching.
Usual dose: 6 mg once a day, long term.
Kidney function: No dose change for most levels of reduced kidney function.
Severe liver disease: Not recommended, so tell your doctor about any liver condition before you start.
Twice a day, roughly 12 hours apart, with or without food — food helps some people with nausea. Swallow the tablets whole; do not crush, split or chew them.
Once a day, at whatever time suits you, with or without food. Pick one time and keep to it, because a daily tablet is easy to lose track of in a way a fortnightly injection is not. Attaching it to something you already do, like brushing your teeth at night, works better than intending to remember.
Swallow the tablet whole with water. Do not crush, split or chew it. If it upsets your stomach, take it with a meal.
Take it as soon as you remember, unless the next dose is close, in which case skip it. Never take two at once. If you have stopped for more than a few days, ask before restarting; the full dose brings the stomach side effects straight back, so the starter pack is usually repeated.
Take it as soon as you remember on the same day. If you do not remember until the next day, skip it and take that day's tablet as usual. Never take two in one day. Missing the occasional dose will not undo months of progress, but repeatedly missing them is one of the commonest reasons a treatment looks like it has stopped working.
The absence of blood tests is why many people choose this drug. No baseline blood count, no liver panel, no tuberculosis test, no hepatitis screen, nothing repeated. Kidney function is checked once before starting, because severe impairment halves the dose.
What replaces it is clinical monitoring, which is not lighter, only different. Weight comes first. Weight loss is common and can be substantial, with some people losing five to ten percent of their body weight. If you wanted that, it is welcome. If you are older, frail or already underweight, it is a reason to reconsider, and unexplained loss should prompt a review.
Mood is second. Depression, low mood and, rarely, suicidal thoughts have been reported and appear on the label. The risk is low, but new or worsening depression should be reported promptly, and a history of depression belongs on the record before you start.
Diarrhea and nausea are third. They usually settle within the first few weeks, but severe or persistent diarrhea is not something to push through. In older adults, and in anyone on a water tablet or a blood pressure medicine, it has caused dehydration and kidney injury.
The one scheduled checkpoint is the 16-week review of skin or joints. If nothing meaningful has changed, continuing is not useful.
Everyone is screened for tuberculosis before starting, with a skin test or a TB blood test, and a chest X-ray if positive. Dormant TB is treated first. This applies even though it is a tablet rather than an injected biologic.
Hepatitis B and C are usually checked at the same time.
Liver blood tests are often checked before starting and again if there is a reason to. Some people show a rise in creatine kinase, a muscle enzyme, or in triglycerides, so those may be looked at too. There is no rigid schedule like methotrexate's; how often anything is repeated is your doctor's judgment.
The rest is clinical. Report repeated infections, cold sores that keep coming back, mouth ulcers that will not heal, and unexplained muscle pain. Skin should be checked periodically, as on any drug that damps down the immune response.
Approximate windows, not promises.
First doseStarting: The starter pack steps the dose up over the first week, which softens the early side effects.
First doseTaking it: One tablet a day, with or without food.
Days 1 to 14Adjusting: Loose stools, nausea and headache usually start in the first week or two and settle within a month.
Weeks 2 to 4Itch: Usually the first thing to change, ahead of the plaques. Behcet's mouth ulcers settle here too, one of the faster and more reliable responses.
Weeks 4 to 8Working: The first visible change in the skin. Scale lifts before the redness fades.
Weeks 12 to 16Judge it here: In the trials roughly one in three people reached a 75 percent improvement. Scalp psoriasis responds better than thick body plaques, a common reason to choose it.
Weeks 16 to 24Psoriatic arthritis: Joint pain, swelling and tenderness improve.
Months 3 and onwardWeight and mood: Weight loss comes on gradually, so weigh yourself regularly rather than going by how clothes feel. Mood changes are uncommon but worth watching.
Months 6 and beyondNails: The slowest of all, because a nail has to grow out before improvement shows.
Weeks 1 to 4Starting: Itch usually eases before the plaques look different. Early side effects show now, most often a cold, a cold sore or a mouth ulcer.
Weeks 4 to 16Working: Scale lifts and plaques flatten steadily. Scalp psoriasis often improves noticeably here, before the trunk.
Week 16Judge it here: Where the trials measured, and the fair point to decide. More than half reached at least a 75 percent improvement in how much skin was involved and how severe it was; a smaller share were clear or nearly clear.
Months 3 to 6Palms and soles: Stubborn on every treatment, slower than plaques elsewhere.
Months 6 to 12Nails: Nails change last, because a nail takes months to grow out. Judge the new growth at the base, not the damaged tip.
Beyond 16 weeksLong term: Responders often keep improving slowly through the first year. Because it is a small molecule, the body does not make antibodies against it, so the gradual loss of effect seen with some injected drugs is not an issue here.
Sorted by what to do about them.
Apremilast is expensive, priced far closer to the biologics than to older oral drugs such as methotrexate or acitretin.
So insurers commonly ask that cheaper options be tried first, and prior authorization is usual. The manufacturer runs a copay assistance program, which typically helps people with commercial insurance and is not available on government plans.
What it saves is indirect: no injection supplies, no screening tests, no repeated laboratory work. That does not close the gap with a generic tablet, but it is part of the comparison.
Brand only. There is no generic and will not be for years, so there is no cheaper equivalent. The list price is high, in the same range as the injected biologics over a year, which surprises people who assume a tablet must be cheaper.
Almost nobody pays it. What matters is what your plan does, and approval takes paperwork. Prior authorization is close to universal, and most plans want documented failure of something cheaper first: phototherapy, methotrexate or apremilast.
Manufacturer copay cards can bring the monthly cost down to very little on commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or no insurance, the manufacturer's patient assistance program and independent foundations are the usual routes, and the rules change regularly.
One thing in its favor on cost: no infusion visits, no injection training, no cold chain, so the costs around the drug are lower even when the drug is not.
Correct. No monitoring schedule, no tuberculosis screen, no repeated bloodwork. Kidney function is checked once before starting, because severe impairment halves the dose.
For most people it is worst in the first two weeks and settles within a month, which is what the five-day starter pack softens. Diarrhea that is severe or lasts past a month is a reason to be reviewed.
Some people do, and some of them lose five to ten percent of their body weight. It happens gradually, so weigh yourself every few weeks rather than judging by how clothes fit.
Less effective for thick plaques — about one in three reached a seventy-five percent improvement at 16 weeks, where biologics reach much higher figures. What it offers is a tablet, no needles, no screening, no monitoring.
Low mood and depression are uncommon but on the label, and rare reports of suicidal thoughts exist. Report any new or worsening low mood promptly.
About 16 weeks for the skin, up to 24 weeks for joints. If nothing meaningful has changed, continuing is not worthwhile.
It works on TYK2, an enzyme in the same family, but binds a different part of it and is far more selective. Its label does not carry the boxed warning the JAK inhibitors carry. The distinction is real, not marketing.
On average the injected biologics clear skin more completely. This clears skin well for a lot of people, and it is a daily tablet with no fridge and no needles. Which trade is right depends on how severe your psoriasis is and how you feel about needles.
Tuberculosis and hepatitis before you start, and usually liver tests. After that, testing follows your situation, not a fixed schedule — much lighter than methotrexate monitoring.
Herpes simplex outbreaks and mouth ulcers are commonly reported. Tell your doctor if they are frequent; they can usually be managed without stopping.
No direct interaction, unlike methotrexate. Ordinary drinking is generally not a problem, but confirm with your doctor if you have a liver condition.
Losing response over time is less of an issue than with injected antibodies, since the body makes no antibodies against a small molecule. If it does stop working, the option is switching class, since there is no higher dose.